TG Therapeutics | DEBITO



Debt Cambiamento Data
AbbVie USD 67.14B 3.94B 2024-12
Alaunos Therapeutics USD 0 0 2024-09
Amgen USD 60.1B 299M 2024-12
Ardelyx USD 150.85M 50.15M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Bayer EUR 40.7B 465M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Dynavax Technologies USD 223.85M 293K 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
J&J USD 36.63B 883M 2024-12
Novartis USD 31.26B 828M 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
TG Therapeutics USD 244.43M 271K 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



TG Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.